Elanco Animal Health (ELAN) Intangibles (2017 - 2026)
Elanco Animal Health (ELAN) posted Intangibles of $3.2 billion for Q1 2026, down 5.37% sequentially from $3.4 billion in Q4 2025, and down 11.25% YoY from $3.6 billion in Q1 2025.
Elanco Animal Health (ELAN) Intangibles (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Intangibles for 10 years, with the latest figure at $3.2 billion in Q1 2026.
- Quarterly Intangibles fell 11.25% year-over-year to $3.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 billion (down 11.25% YoY) and the FY2025 annual result came in at $3.4 billion, down 7.42% from the prior year.
- Intangibles fell to $3.2 billion in Q1 2026 per ELAN's latest filing, from $3.4 billion in the prior quarter.
- Over five years, Intangibles peaked at $5.4 billion in Q1 2022 and troughed at $3.2 billion in Q1 2026.
- A 5-year average of $4.2 billion and a median of $4.2 billion in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2023 and 2024: Intangibles dropped 6.11% in 2023, then fell 18.09% in 2024.
- Over 5 years, Intangibles stood at $4.8 billion in 2022, then declined by 7.19% to $4.5 billion in 2023, then retreated by 18.09% to $3.7 billion in 2024, then fell by 7.42% to $3.4 billion in 2025, then declined by 5.37% to $3.2 billion in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $3.2 billion, $3.4 billion, and $3.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 1.12 Bn |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 1.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.20 Bn |
| Mar 31, 2026 | 3.23 Bn |
| Dec 31, 2025 | 3.41 Bn |
| Sep 30, 2025 | 3.60 Bn |
| Jun 30, 2025 | 3.71 Bn |
| Mar 31, 2025 | 3.63 Bn |
| Dec 31, 2024 | 3.68 Bn |
| Sep 30, 2024 | 4.01 Bn |
| Jun 30, 2024 | 4.00 Bn |
| Mar 31, 2024 | 4.20 Bn |
| Dec 31, 2023 | 4.49 Bn |
| Sep 30, 2023 | 4.48 Bn |
| Jun 30, 2023 | 4.68 Bn |
| Mar 31, 2023 | 4.79 Bn |
| Dec 31, 2022 | 4.84 Bn |
| Sep 30, 2022 | 4.77 Bn |
| Jun 30, 2022 | 5.06 Bn |
| Mar 31, 2022 | 5.40 Bn |
| Dec 31, 2021 | 5.59 Bn |
| Sep 30, 2021 | 5.82 Bn |